DENTSPLY SIRONA Announces Executive and Board Changes
Ticker: XRAY · Form: 8-K · Filed: 2024-08-20T00:00:00.000Z
Sentiment: neutral
Topics: executive-changes, board-changes, management-transition
TL;DR
DENTSPLY SIRONA shakes up exec team and board, new CFO appointed.
AI Summary
DENTSPLY SIRONA Inc. announced on August 15, 2024, changes in its executive leadership and board of directors. The company appointed a new Chief Financial Officer and made several other executive and director changes, effective immediately. These changes are part of the company's ongoing strategic initiatives.
Why It Matters
Changes in key leadership roles can signal shifts in company strategy, financial priorities, or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and execution, warranting close monitoring by investors.
Key Players & Entities
- DENTSPLY SIRONA Inc. (company) — Registrant
- August 15, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 39-1434669 (tax_id) — I.R.S. Employer Identification No.
- 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (address) — Principal Executive Address
FAQ
What specific executive positions were affected by the changes announced on August 15, 2024?
The filing indicates changes in executive leadership, including the appointment of a new Chief Financial Officer, and other executive and director changes.
When were these changes effective?
The changes were effective immediately as of August 15, 2024.
What is the primary reason cited for these changes?
The filing states these changes are part of the company's ongoing strategic initiatives.
What is DENTSPLY SIRONA Inc.'s state of incorporation?
DENTSPLY SIRONA Inc. is incorporated in Delaware.
What is the address of DENTSPLY SIRONA Inc.'s principal executive offices?
The address is 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607.
From the Filing
0000818479-24-000072.txt : 20240820 0000818479-24-000072.hdr.sgml : 20240820 20240820061536 ACCESSION NUMBER: 0000818479-24-000072 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240815 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 241222551 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20240815.htm 8-K xray-20240815 0000818479 false 0000818479 2024-08-15 2024-08-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 15, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of Principal Executive Offices) (Zip Code) ( 844) 848-0137 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 15, 2024, Glenn G. Coleman informed DENTSPLY SIRONA Inc. (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and principal accounting officer of the Company effective November 7, 2024, to pursue another opportunity. Mr. Coleman’s resignation was not because of any disagreement with the Company on any matter relati